José-Juan Pereyra-Rodríguez-rekin lankidetzan egindako argitalpenak (22)

2024

  1. Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up

    Dermatitis, Vol. 35, pp. S55-S61

  2. Real-World Safety and Efficacy Profile of Baricitinib in Patients With Atopic Dermatitis: a Multicenter Retrospective Trial From Four Spanish Hospitals in Andalusia

    Actas Dermo-Sifiliograficas

2023

  1. Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus

    Acta Dermato-Venereologica, Vol. 103

  2. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results

    Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997

  3. Upadacitinib for moderate to severe atopic dermatitis

    Immunotherapy, Vol. 15, Núm. 11, pp. 799-808

2022

  1. Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

    Life

  2. Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review

    Life, Vol. 12, Núm. 8

  3. Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning

    International journal of environmental research and public health, Vol. 19, Núm. 17

2021

  1. 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

    Anais Brasileiros de Dermatologia, Vol. 96, Núm. 6, pp. 787-790

  2. Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study

    British Journal of Dermatology

  3. Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis

    Life, Vol. 11, Núm. 9

2020

  1. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228

  2. Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain

    Dermatologic Therapy, Vol. 33, Núm. 6

  3. The Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 699-700

2019

  1. Development and validation of a questionnaire to measure empowerment in adult patients with atopic dermatitis. The DATEMP questionnaire

    JDDG - Journal of the German Society of Dermatology, Vol. 17, Núm. 9, pp. 923-931

  2. Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study

    Journal of the European Academy of Dermatology and Venereology

  3. Entwicklung und Validierung eines Fragebogens zur Messung des Empowerments bei erwachsenen Patienten mit atopischer Dermatitis. Der DATEMP-Fragebogen

    JDDG - Journal of the German Society of Dermatology, Vol. 17, Núm. 9, pp. 923-932

  4. Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

    Dermatologic Therapy, Vol. 32, Núm. 4

  5. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series

    British Journal of Dermatology

2018

  1. Empowerment in Dermatology

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 2, pp. 133-139